Results 11 to 20 of about 888 (186)

The Hemodynamic Effect of Enhanced External Counterpulsation Treatment on Atherosclerotic Plaque in the Carotid Artery: A Framework of Patient-Specific Computational Fluid Dynamics Analysis

open access: yesCardiology Research and Practice, 2020
Long-term enhanced external counterpulsation (EECP) therapy has been recommended for antiatherogenesis in recent clinical observations and trials. However, the precise mechanism underlying the benefits has not been fully clarified. To quantify the effect
Jianhang Du   +9 more
doaj   +3 more sources

Enhanced External Counterpulsation (EECP) dan Arah Masa Depan

open access: yesMajalah Kardiologi Indonesia, 2013
Diperkirakan 6,4 juta pasien di USA menderita penyakit jantung koroner (PJK) simptomatik (Coronary Artery Disease/CAD), dan sekitar 400.000 kasus baru muncul tiap tahunnya.
Djanggan Sargowo
doaj   +3 more sources

The Ethanol Extract of the Inner Bark of Caesalpinia pyramidalis (Tul.) Reduces Urinary Bladder Damage during Cyclophosphamide-Induced Cystitis in Rats [PDF]

open access: yesThe Scientific World Journal, 2013
Hemorrhagic cystitis (HC) is a common side effect of cyclophosphamide therapy, which deserves new therapeutic strategies, such as those based on natural products.
Janaína P. Moraes   +8 more
doaj   +3 more sources

The Effect of Enhanced External Counterpulsation Therapy and Improvement of Functional Capacity in Chronic Heart Failure patients: a Randomized Clinical Trial

open access: yesActa Medica Indonesiana, 2015
Aim: to investigate the efficacy of enhanced external counterpulsation (EECP) therapy to improve functional capacity in patients with chronic heart failure (CHF).
Starry H Rampengan   +3 more
doaj   +6 more sources

Enhanced external counterpulsation as an effective nonsurgical solution for ischemic heart disease patients

open access: yesHeart India, 2017
Stable angina is managed primarily through lifestyle advice, medication therapy, and coronary revascularization procedures. Some patients with refractory angina exhibit symptoms that are not optimally controlled with the optimal medication and ...
Sanjay Kumar, T K Lahiri
doaj   +2 more sources

Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris

open access: yesClinical Cardiology, Volume 44, Issue 2, Page 160-167, February 2021., 2021
Background Enhanced external counterpulsation (EECP) is a noninvasive treatment that can decrease limiting symptoms in patients with refractory angina pectoris (RAP).
Wu, Eline   +11 more
core   +2 more sources

Efek Enhanced External Counterpulsation Terhadap Perbaikan Kontraktilitas Miokard yang masih viabel pada penderita penyakit jantung koroner

open access: yesMajalah Kardiologi Indonesia, 2013
Objective: To obtain data about the effect of EECP on dysfunctional but viable myocardial contractility in patient with coronary heart disease. Methods: This is an experimental study which include twenty male coronary heart disease but viable myocardium.
Utojo Lubiantoro   +2 more
doaj   +2 more sources

Reduction in the risk of contrast-induced nephropathy using enhanced external counter-pulsation in patients with chronic kidney disease. [PDF]

open access: yesRen Fail
Objective To evaluate the efficacy of EECP in the prevention of contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD).Methods A prospective trial was undertaken in the participants.
Zeng CM   +5 more
europepmc   +2 more sources

Enhanced external counter pulsation as a novel therapy to maintain cardiac output during hemodialysis: a preliminary randomized controlled study. [PDF]

open access: yesSci Rep
Intradialytic cardiac output (CO) decline normally occurs during hemodialysis (HD) and results in short-term intradialytic hypotension to longer-term increased cardiovascular morbidity and mortality in chronic HD patients.
Thongsricome T   +6 more
europepmc   +2 more sources

Cardiovascular Effects of Long-Term Treatment with Enhanced External Counterpulsation in Patients with Ischemic Heart Failure: Randomized, Placebo-Controlled, Open-Label Clinical Trial. [PDF]

open access: yesJ Cardiovasc Dev Dis
(1) Background. Although treatment with enhanced external counterpulsation (EECP) in patients with ischemic chronic heart failure (CHF) is pathophysiologically justified, its long-term vascular effects remain insufficiently defined. We aimed to study the
Lishuta AS   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy